Literature DB >> 12510808

Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.

L Gómez-García1, P Esbrit, L Carreño, P Sabando, M García-Flores, M E Martinez.   

Abstract

The bisphosphonate alendronate is a potent inhibitor of bone resorption by its direct action on osteoclasts. In addition, there is some data suggesting that alendronate could also inhibit bone resorption indirectly by interacting with osteoblasts. Parathyroid hormone-related protein (PTHrP) produced by osteoblasts and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] are regulators of bone remodeling, which have interrelated actions in these cells. In this study, we assessed whether alendronate can affect PTHrP expression in the presence or absence of 1,25(OH)2D3 in human primary osteoblastic (hOB) cells from trabecular bone. Cell total RNA was isolated, and semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was carried out using human PTHrP-specific primers. PTHrP in the hOB cell-conditioned medium was analyzed by a specific immunoradiometric assay. We found that PTHrP mRNA and secreted PTHrP were maximally inhibited by 10(-8) - 10(-6) M of 1,25(OH)2D3 treatment within 8-72 h in hOB cells. Alendronate (10(-14) - 10(-8) M) modified neither PTHrP mRNA nor PTHrP secretion, although it consistently abrogated the decrease in PTHrP production induced by 1,25(OH)2D3 in these cells. On the other hand, alendronate within the same dose range did not affect either the vitamin D receptor (VDR) mRNA or osteocalcin secretion, with or without 1,25(OH)2D3, in hOB cells. The inhibitory effect of alendronate on the 1,25(OH)2D3-induced decrease in PTHrP in these cells was mimicked by the calcium ionophore A23187 (5 x 10-6 M), while it was eliminated by 5 x 10(-5) M of nifedipine. Furthermore, although alendronate alone failed to affect [Ca2+]i in these cells, it stimulated [Ca2+]i after pretreatment of hOB cells with 10(-8) M of 1,25(OH)2D3, an effect that was abolished by 5 x 10(-5) M of nifedipine. These results show that alendronate disrupts the modulatory effect of 1,25(OH)2D3 on PTHrP production in hOB cells. Our findings indicate that an increase in calcium influx appears to be involved in the mechanism mediating this effect of alendronate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12510808     DOI: 10.1359/jbmr.2003.18.1.78

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  4 in total

1.  The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.

Authors:  Anna Enjuanes; Silvia Ruiz-Gaspà; Pilar Peris; Dolores Ozalla; Luisa Alvarez; Andrés Combalia; M Jesús Martínez de Osaba; Ana Monegal; Albert Pares; Nuria Guañabens
Journal:  Endocrine       Date:  2010-01-07       Impact factor: 3.633

2.  The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblasts.

Authors:  Anna Enjuanes; Silvia Ruiz-Gaspà; Pilar Peris; Dolores Ozalla; Luisa Álvarez; Andrés Combalia; M Jesús Martínez de Osaba; Ana Monegal; Albert Pares; Nuria Guañabens
Journal:  Endocrine       Date:  2009-11-24       Impact factor: 3.633

3.  Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment.

Authors:  Maciej J K Simon; Peter Niehoff; Bernhard Kimmig; Jörg Wiltfang; Yahya Açil
Journal:  Clin Oral Investig       Date:  2009-07-14       Impact factor: 3.573

4.  The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene?

Authors:  Maria Teresa Valenti; Francesco Bertoldo; Luca Dalle Carbonare; Giuseppe Azzarello; Sonia Zenari; Mirko Zanatta; Elena Balducci; Orazio Vinante; Vincenzo Lo Cascio
Journal:  BMC Cancer       Date:  2006-03-03       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.